HAIC Plus Lenvatinib and Toripalimab for Advanced HCC

Clinical trial NCT04044313 · COMPLETED

Trial details

NCT number: NCT04044313
Sponsor: Shi Ming
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Hepatocellular Carcinoma

Start date: 2019-08-01
Primary completion: 2021-02-01
Enrollment: 36

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.